Evidence map›Paper›PMID 32884486›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2020

May Measurement Month 2018: an analysis of blood pressure screening campaign results from Poland.

Piotr Jankowski, Maciej Banach, Jolanta Małyszko, Mirosław Mastej, Andrzej Tykarski, Krzysztof Narkiewicz, Piotr Hoffman, Michał P Nowicki, Tomasz Tomasik, Adam Windak and 10 more

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. May Measurement Month 2021: an analysis of blood pressure screening results from Poland.European heart journal supplements : journal of the European Society of Cardiology · 2024
    Article
  3. Military Blood Service in Poland.Journal of blood medicine · 2023
    Article
  4. Article
  5. May Measurement Month 2019: an analysis of blood pressure screening results from Poland.European heart journal supplements : journal of the European Society of Cardiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Piotr JankowskiI Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, Kraków 31-501, Poland.
Maciej BanachDepartment of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Żeromskiego 113, Łódz 90-549, Poland.
Jolanta MałyszkoDepartment of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, Banacha 1a, Warszawa 02-097, Poland.
Mirosław MastejMastej Medical Center, Staszica 21, Jasło 38-200, Poland.
Andrzej TykarskiDepartment of Hypertension, Angiology and Internal Medicine, Poznan University of Medical Sciences, Długa1/2, Poznan 61-848, Poland.
Krzysztof NarkiewiczDepartment of Hypertension and Diabetology, Medical University of Gdańsk, Dębinki 7, Gdansk 80-952, Poland.
Piotr HoffmanDepartment of Congenital Heart Disease, Institute of Cardiology, Alpejska 42, Warszawa 04-628, Poland.
Michał P NowickiDepartment of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Pomorska 251, Łódz 92-213, Poland.
Tomasz TomasikDepartment of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bocheńska 4, Kraków 31-061, Poland.
Adam WindakDepartment of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bocheńska 4, Kraków 31-061, Poland.
Agnieszka OlszaneckaI Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, Kraków 31-501, Poland.
Maciej TomaszewskilDivision of Cardiovascular Sciences, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.
Agnieszka MotylMedicover Poland, Jerozolimskie 96, Warszawa 00-807, Poland.
Dariusz NowakMunicipal Hospital, Mickiewicza 12, Częstochowa 42-200, Poland.
Łukasz SkowronDepartment of Gastroenterology, Endocrinology and Internal Diseases, Military Institute of Medicine, Szaserów 128, Warszawa 04-141, Poland.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Anca Chis SterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Xia XinImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Jacek JóźwiakDepartment of Family Medicine and Public Health, Faculty of Medicine, University of Opole, Oleska 48, Opole 45-052, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension remains the most important cardiovascular risk factor in Poland. May Measurement Month is a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for blood pressure (BP) screening and demonstrating the potential of the opportunistic BP measurements. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in 146 sites in May 2018. Blood pressure was measured in 6450 subjects (mean age: 41 ± 15 years; 59% females). After multiple imputation, the age and sex standardized systolic and diastolic BP was 126.7/78.4 mmHg in the whole analysed group, 132.8/81.3 mmHg in subjects taking antihypertensive drugs, and 125.7/78.0 mmHg in those not taking any antihypertensive drugs. After multiple imputation, the proportions of subjects with high BP (systolic ≥140 mmHg or diastolic ≥90 mmHg or on treatment for raised BP) were 22.2% in the whole analysed group, 39.2% in subjects taking antihypertensive drugs, and 18.6% those not taking any antihypertensive drugs. Overall, hypertension was present in 32.8% of participants, among them 38.7% were not aware of the disease, 53.1% were taking antihypertensive drugs, and 32.3% had BP controlled to target (<140/90 mmHg). Blood pressure was increasing with increasing body mass index and alcohol intake. Smokers and project participants with diabetes had increased average BP. In conclusion, this project provides additional evidence for a considerable potential for further reduction of cardiovascular risk through improvement in detection and treatment of hypertension in Poland.

Indexed as

Blood pressureControlDisease awarenessHypertensionScreeningTreatment

Identifiers

PMID32884486
PMCPMC7455275

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.